Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict Mortality.

Ralph C WardDavid J TaberRobert Neal AxonMulugeta Gebregziabher

Published in: Pharmacotherapy (2018)

Investigators using PDC or similar proxy measures should carefully consider the temporal relationship between adherence exposure and clinical outcomes when the outcome event affects the adherence measurement.

Keyphrases

glycemic control
type diabetes
human health
adipose tissue
weight loss